Schedule At A Glance

    With these great sessions, WCIO 2016 is shaping up to be our best educational event yet. We will be updating this page with event and registration details, so please check back often! We’ll see you in Boston this June!

    Wednesday, 8 June
    Time General Session Speaker(s)
    Early Career Part 1
    1:00 pm–1:10 pm  Welcome and Introduction Kevin Kim, MD and Constantinos Sofocleous, MD, PhD
    1:10 pm–2:10 pm Fundamentals of IO Constantinos Sofocleous, MD, PhD and Kevin Kim, MD
    1:10 pm–1:20 pm What is IO and the Future of IO J.F. Geschwind, MD
    1:20 pm–1:30 pm How To Be a STAR at Tumor Board Michael Soulen, MD
    1:30 pm–1:40 pm Oncology Language Should Be Your Language William S. Rilling, MD
    1:40 pm–1:50 pm Clinical Care in IO Peter Mueller, MD
    1:50 pm–2:00 pm Oncology Practice: Scientific Evidence-Based Stephen Soloman, MD
    2:00 pm–2:10 pm Practical Clinical Practice of Onocology: Crucial and Critical For Your Practice David C. Madoff, MD
    2:15 pm–2:45pm  Science of IO: Pearls on IO Therapies
    J.F. Geschwind, MD and Luigi Solbiati, MD
    2:15 pm–2:30pm Intra Arterial Therapies Daniel Brown, MD
    2:30 pm2:45 pm Ablation Therapies Matthew Callstrom, MD, PhD
    2:50 pm–3:50 pm Non-IO Studies You Must Know Stephen Solomon, MD and Matthew Callstrom, MD, PhD
    2:50 pm– 3:00 pm Liver Cancer Riccardo Lencioni, MD
    3:00 pm–3:10 pm Lung Cancer Thierry de Baere, MD
    3:10 pm–3:20 pm Kidney Cancer Debra Gervais, MD
    3:20 pm–3:30 pm Bone Cancer Muneeb Ahmed, MD
    3:30 pm–3:50 pm Meet the Professor: Q&A J.F. Geschwind, MD; Riad Salem, MD; Luigi Solbiati, MD; Thierry de Baere, MD; Debra Gervais, MD; Muneeb Ahmed; Stephen Solomon, MD; Peter Mueller, MD; David C. Madoff, MD
    3:50 pm–4:10 pm Short Break
    4:10 pm–5:10 pm Tumor Board Match
    4:10 pm4:30 pm Quarterfinal: Southeast vs. West Michael Soulen, MD vs. Daniel Brown, MD
    4:30 pm–4:50 pm Quarterfinal: Northeast vs. Midwest Constantinos Sofocleous, MD, PhD vs. Robert Lewandowski, MD
    4:50 pm–5:10 pm Final Winners from Quarter Final
    5:20 pm–6:00 pm Clinical IO Daniel Brown, MD and Govindarajan Narayanan, MD
    5:20 pm5:30 pm How To Build A Clinical IO Practice Daniel Brown, MD
    5:30 pm–5:40 pm Business of IO Govindarajan Narayanan, MD
    5:40 pm5:50 pm Adopting Outside Forces Afshin Gangi, MD
    5:50 pm–6:00 pm I Like IO: How Can I Become One? Alban Denys, MD
    Thursday, 9 June
    Time General Session Speaker(s)
    7:30 am–8:15am NeuWave Symposium: Principles of Microwave Ablation Constantinos Sofocleous, MD, PhD; Roger Williams, DO; David Breen, MD, MRCP, FRCR; Matthew Callstrom, M.D., Ph.D.
    8:30 am–9:00 am Breakfast and Exhibits
    9:00 am9:05am Welcome and Introduction Jeff Geschwind, MD and Constantinos Sofocleous, MD, PhD
    9:00 am–10:15 am HCC, Part 1 David Madoff, MD and Bien-Soo Tan, MD
    9:05 am–9:17 am Update on Clinical Guidelines for HCC: From Clinic to Research Kevin Kim, MD
    9:17 am9:29 am Surgical Options for HCC: Rational and Outcomes - IO As A Bridge To Transplant? Parsia Vagefi, MD
    9:29 am–9:41 am Role of Ablation: When Can It Be The First Line Therapy? Luigi Solbiati, MD
    9:41 am9:53 am Transarterial Therapies for HCC: Can We Expand the Indications Yasuaki Arai, MD
    9:53 am–10:05 am Systemic Therapies for HCC: When Does It Make A Difference? Andrew Zhu, MD
    10:05 am10:15am Best 2016 WCIO Abstract: A Tumor-Penetrating Peptide Integrated Thermo-sensitive Liposomal Doxorubicin Enhances the Efficacy of Drugs Accumulation and Animal Survival Song Wang
    10:25 am–11:25 am Molecular Pathways in IO Muneeb Ahmed, MD and J.F. Geschwind, MD
    10:25 am10:50 am Targeting Therapies In IO S. Nahum Goldberg, MD
    10:50 am11:00 am Angiogenesis In Cancer Dan G. Duda, DMD, PhD
    11:00 am11:25 am Hypoxia In IO J.F. Geschwind, MD
    11:25 am–11:55 am Break and Exhibits
    11:55 am1:25 pm MSK Alessandro Napoli, MD and Sean Tutton, MD
    11:55 am12:05 pm Periacetabular Ablation and Augmentation Matthew Callstrom, MD, PhD
    12:05 pm12:15 pm Local Control with SBRT
    12:15 pm12:25 pm Local Control of RCC Metastases with Ablation Anil "Nick" Kurup, MD
    12:25 pm12:35pm Palliation and Local Control In the Spine Sean Tutton, MD
    12:35 pm12:45 pm MRI Guided Focused US Palliation and Local Control Alessandro Napoli, MD
    12:45 pm12:55pm Tips and Tricks with MSK Ablation Afshin Gangi, MD
    12:55 pm1:30 pm Tumor Board Moderators: Matthew Callstrom, MD and Alexis Kelekis, MD
    11:55 am–1:25 pm Y90 from A-Z: A Mini Course Constantinos Sofocleous, MD, PhD and Riad Salem, MD
    11:55 am12:08 pm Radiation Safety Andrew Kennedy, MD
    12:08 pm12:21 pm Therapy Planning: The Basics Nishita Kothary, MD
    12:22 pm12:35 pm My Best Cases: A Case-Based Review - Resin Fred Moeslein, MD
    12:35 pm12:47 pm My Best Cases: A Case-Based Review - Glass Robert Lewandowski, MD
    12:47 pm1:00 pm State of the Art: Personalized Dosimetry Marnix Lam, MD
    1:00 pm1:13 pm Therapy Planning: Can We Stop Mapping? Riad Salem, MD
    1:13 pm1:25 pm Case-Based Review of Y90 Moderators: Robert Lewandowski, MD and Nishita Kothary, MD
    1:30 pm2:50pm Lunch Symposia
    1:30 pm2:10 pm Outcomes of Y90 for HCC and Liver Metastases Riad Salem, MD and Constantinos Sofocleous, MD, PhD
    2:10 pm2:50 pm Medtronic Symposium: New Frontiers in Ablative Therapies
    Moderator: Matthew Callstrom, M.D., Ph.D. Speakers: Philippe Pereira, MD and Jack Jennings, MD
    2:50 pm–3:20 pm Break and Exhibits
    3:20pm–3:50pm Why Are We Here? Michael Brunner, MD and Michael Soulen, MD
    3:20 pm3:30 pm Introduction and Welcome from SIR President Alan Matsumoto, MD
    3:30 pm 3:40 pm How Interventional Oncology Helped My Fight Against Cancer Patricia Hagerman
    3:35 pm3:50 pm How IO Helped Me Fight Cancer Liya Khenkin
    3:40 pm4:05 pm Break and Exhibits
    4:05 pm5:05 pm WCIO Welcomes Radiation Oncology: Synergistic Pathways Andreas Adam, MD and Damian Dupuy, MD
    4:05 pm4:15 pm IO: The 4th Pillar in Cancer Care Andreas Adam, MD
    4:15 pm4:25pm QA &IO: What Radiation Therapy Can Teach Us Lizbeth Kenny, MD
    4:25 pm4:35 pm Image Targeted Oncology: Convergence of Disciplines Anthony Zietman, MD
    4:35 pm4:45 pm ASTRO and WCIO: Synergies Stephen Solomon, MD
    4:45 pm5:05pm Theory to Practice: Synergy DMT Tumor Board Moderator: Damina Dupuy, MD
    4:05 pm5:05 pm Asia Meets WCIO: How We Treat Primary Liver Cancer in Asia Uei Pua, MD and Kevin Kim, MD
    4:05 pm4:17pm Radiofrequency Ablation for Hepatocellular Carcinoma: Lessons from 8,000 Procedures
    Hyunchul Rhim, MD
    4:17 pm4:29 pm Radiofrequency and Microwave Ablation in Liver Neoplasm Yi-You Chiou, MD
    4:29 pm4:41 pm Challenges in Liver Tumor Ablation Uei Pua, MD
    4:41 pm4:53 pm Hepatic Arterial Chemo-Infusion: Current Status in Japan Haruyuki Takaki, MD
    4:53 pm5:05 pm A Novel Irradiation Stent Loaded with I-125 Seeds in the Malignant Biliary Tract Obstruction Gao Jun Teng, MD
    5:05 pm5:20 pm Break and Exhibits 
    5:20 pm–6:20 pm Future Trends in IO Treatments Bradford Wood, MD and Fred Lee, MD
    5:20 pm5:35 pm Ablation Devices: New Developments Muneeb Ahmed, MD
    5:35 pm5:50 pm HIFU: Current and Future Applications Franco Orsi, MD
    5:50 pm6:05 pm Bacterial Therapies and Cancer Ravi Murthy, MD
    6:05 pm6:20 pm IO In Pancreatic Cancer Govindarajan Narayanan, MD
    5:20 pm6:20 pm WCIO Around the World Tumor Board Stephen Solomon, MD; William Rilling, MD; Philippe Pereira, MD; and Ricardo Garcia-Monaco, MD
    Asia: China, Japan, and Singapore Ren-Jie Yang, MD; Yasuaki Arai, MD; Tan Bien Soo, MD
    Europe: Germany and France Thomas Helmberger, MD; Thierry de Baere, MD; Philippe Pereira, MD
    Latin America: Argentina and Brazil Marcos Roberto de Menezes, MD; Ricardo Garcia-Monaco, MD
    Middle East: Egypt and Israel Mohamed Shaker, MD; Eldad Elnekave, MD
    India Nitin Shetty, MD; Naveen Kalra, MD; M.C. Uthappa, MD
    6:15 pm–8:00 pm IO Around the World Reception
    Early Career Program, Part 2
    7:00 pm–7:10 pm Welcome and Introduction Riccardo Lencioni, MD
    7:10 pm–7:20 pm Why We Need More IO Research: Opportunities and Challenges J.F. Geschwind, MD
    7:20 pm–7:30 pm From Bench to Bedside: The Role of Basic and Translational Research in IO Joseph Erinjeri, MD
    7:30 pm–7:40 pm Building Up an IO Research Lab – How I Get Started S. Nahum Goldberg, MD
    7:40 pm–7:50 pm Biopsy and Interventional Oncology Constantinos Sofocleous, MD, PhD
    7:50 pm–8:00 pm Designing and Managing a Clinical Trial: What an IO Needs to Know Riad Salem, MD
    8:00 pm–8:10 pm Large Database Population Research in Interventional Oncology Kevin Kim, MD
    8:10 pm–8:20 pm Grants and Funding Opportunities Bradford Wood, MD
    8:20 pm–8:30 pm The Mentor and Mentee Relationship Michael C. Soulen, MD
    Friday, 10 June
    Time General Session Speaker(s)
    7:00 am–7:45 am BTG Symposium: Dosimetry from the Clinical Perspective: Why Dose Matters and Personalizing Treatment with TheraSphere® Marnix Lam, MD, PhD; Riad Salem, MD, MBA
    8:00 am–9:30 am Workshop: Ablative Therapies 101 Moderator: Bradley Pua, MD      
    Speakers: Christos Georgiades, MD; Servet Tatli, MD; Miltiadis Krokidis, MD; Sohail Contractor, MD
    8:00 am–9:30 am
    Abstract Presentations: Lung, Kidney, Prostate, Bone Moderator: Jacob Cynamon, MD
    9:30 am–10:00 am Breakfast and Exhibits
    10:00 am11:00am Systemic Effects of IO Therapy Joseph Erinjeri, MD
    10:00am–10:15am Immunology and Cancer Silvia Formenti, MD
    10:15 am–10:30am Ablation as a Vaccine Against Cancer Joseph Erinjeri, MD
    10:30 am10:40 am Tumorigenesis in IO Muneeb Ahmed, MD
    10:45 am–11:00 am Targeting the AKT Pathway: Implications for IO David Woodrum, MD, PhD
    11:00 am–11:30 am Break and Exhibits
    11:30 am–12:30 pm Primary Lung Cancer   Robert Suh, MD and Amita Sharma, MD
    11:30 am–11:42 am Lung Cancer Screening Bradley Pua, MD
    11:42 am–11:54 am Targeted Therapies for Lung Cancer Daniel Costa, MD
    11:54 am–12:06 pm Is Parenchyma Sparing Surgery Ready for Prime Time? Michael Lanuti, MD
    12:06 pm–12:18 pm SBRT Can Replace Surgery in Early Stage Primary Lung Cancer Stuart Berman, MD
    12:18 pm–12:30 pm Lung Cancer Ablation: Still a Great Option for Early Non-Small Cell Lung Cancer Robert Suh, MD
    11:30 am–12:30 pm Most Influential Publications of 2015 - 2016 David Madoff, MD and Joseph Erinjeri, MD
    12:45 pm–2:10 pm Lunch Symposia
    12:45 pm–1:25 pm BTG Symposium: An Extended View from Users of LC Bead LUMI™ in Combination with Philips Image Guidance
    Edward Kim, MD, FSIR; Kevin Kim, MD; Jeff Geschwind, MD
    1:30 pm–2:10 pm NeuWave Medical Symposium: The Latest Advances in Ablation
    Constantinos Sofocleous, MD, PhD; David Lu, MD; Roger Williams, DO; Louis Hinshaw, MD, FSAR
    2:10 pm–2:45 pm Break and Exhibits 
    2:45 pm–3:45 pm HCC Tumor Board
    Moderators: Daniel Brown, MD; Johannes Lammer, MD; Yasuaki Arai, MD
    Panelists: Karen Brown, MD; J.F. Geschwind, MD; Michael C. Soulen, MD; Bien Soo Tan, MD 
    3:45 pm-4:00 pm Break and Exhibits
    4:00 pm–5:00 pm Biomarkers and Advances in Imaging  Constantinos Sofocleous, MD, PhD
    and Kevin Kim, MD
    4:00 pm–4:15 pm Genomics and Precision Medicine Ryan Corcoran, MD
    4:15 pm–4:30 pm Biomarkers and Intraarterial Therapies Kevin Kim, MD
    4:30 pm–4:45 pm Biomarkers for Ablation Constantinos Sofocleous, MD, PhD
    4:45 pm–5:00 pm Surrogate Image Biomarkers in IO Bradford Wood, MD
    4:00 pm–5:00 pm Lung Metastases and Tumor Board  Thierry de Baere, MD
    4:00 pm–4:10 pm Update On Ablation Data for Pulmonary Metastases Thierry de Baere, MD
    4:10 pm– 4:20 pm Role of Surgery for Pulmonary Metastases Sidhu Gangadharan, MD
    4:20 pm–4:30 pm What Is New With SBRT For Pulmonary Metastases Anand Mahadevan, MD
    4:30 pm–5:00 pm Primary and Metastases Tumor Board Moderators: Alice Gillams, MD; Stephen Solomon, MD; Matthew Callstrom, MD,  PhD
    Panelists: Robert Suh, MD; Christopher Azzoli, MD; Bradley Pua, MD; Daniel Costa, MD; Michael Lanuti, MD; Stuart Berman, MD; Thierry de Baere, MD; Sidhu Gangadharan, MD; Anand Mahadevan, MD
    5:00 pm–5:10 pm Break and Exhibits
    5:10 pm–6:40 pm Workshop: How I Do It Videos David Madoff, MD and Ravi Murthy, MD
    5:10 pm5:25 pm Liver Embolotherapy via a Percutaneous Transradial Approach Aaron Fischman, MD
    5:25 pm–5:40 pm Combined Intraoperative Irreversible Electroporation for Pancreatic Cancer Joshua Weintraub, MD
    5:40 pm5:55 pm Celiac Neurolysis for Intractable Pain from Pancreatic Cancer Ronald Arellano, MD
    5:55 pm–6:10 pm Transcatheter Arterial Chemoembolization for Lung Metastases Thomas Vogl, MD
    6:10 pm– 6:25 pm Interventional MR System for Liver Cancer Therapy Philippe Pereira, MD
    6:25 pm– 6:40 pm High Intensity Focused Ultrasound for the Treatment of Pancreatic Cancer Franco Orsi, MD
    5:10 pm–6:40 pm Abstract Presentation: Basic Sciencec, Spine, and Cryo
    6:30 pm8:00 pm Reception
    Saturday, 11 June
    Time General Session Speaker(s)
    8:00 am–9:30 am Workshop: Transcatheter Hepatic Oncologic Therapies  Sarah White, MD
    8:00 am9:30 am Abstract Presentations Frederic Deschamps, MD
    9:30 am– 10:00 am Breakfast and Exhibits
    10:00 am–11:30 am Metastatic Colorectal Cancer    Thomas Vogl, MD; William Rilling, MD;
    and Luigi Solbiati, MD
    10:00 am–10:15 am Surgery Remains the Gold Standard for CLM Christina Ferrone, MD
    10:15 am–10:30 am When Should Ablation Be The First Line Treatment for CLM Constantinos Sofocleous, MD, PhD
    10:30 am–10:45 am Is It Time For Intraarterial Therapy To Be Used Earlier In the Course of CLM? William S. Rilling, MD
    10:45 am–11:00 am The Case for Integration of Locoregional Therapy with Systemic Therapy Ben George, MD
    11:00 am–11:15 am Adjunctive Liver Regeneration: PVE? Alban Denys, MD
    11:15 am–11:30 am Adjunctive Liver Regeneration: ALPPS? Christina Ferrone, MD
    11:30 am–11:45 am Break and Exhibits
    11:45 am–12:45 pm Renal  Debra Gervais, MD and  David Breen, MD
    11:45 am–11:57 am Partial Nephrectomy: Still the Gold Standard for RCC? Adam Feldman, MD
    11:57 am–12:09 pm Ablation as Efficient as Surgery for Small RCC Thomas Atwell, MD
    12:09 pm–12:21 pm Ablation is Effective for RCC Up to 7cm Jeremy Durack, MD
    12:21 pm–12:33 pm Radio Genomics and Treatment of RCC Debra Gervais, MD
    12:33 pm–12:45 pm Prediciting Complications David Breen, MD
    11:45 am–12:45pm Intrahepatic Cholangiocarcinoma Michael Soulen, MD and David Madoff, MD
    11:45 am–12:00 pm Systemic and IA Chemo Options Nancy Kemeny, MD
    12:00 pm–12:15 pm Surgical Options for Cholangiocarcinoma: What's New A. James Moser, MD
    12:15 pm–12:30 pm Intraarterial Therapy: Current Status Sarah White, MD
    12:30 pm–12:45 pm Update on Clinical Trials Tushar Patel, MD
    12:45 pm–2:10 pm Lunch Symposia
    12:45 pm–1:30 pm CME Session Sponsored by Guerbet Moderator: Michael C. Soulen, MD
    12:45 pm–1:00 pm Management of Portal Hypertension in Cancer Patients Sanjay Saraj Baijal, MD
    1:00 pm–1:15 pm Treatment of Neuroendocrine Liver Metastases Vaibhav Jain, MD
    1:15 pm–1:30 pm Selective Ophthalmic Transarterial Chemoinfusion for Retinoblastoma Suyash Kulkarni, MD
    1:30 pm–2:10 pm GE Symposium: Advances in Interventional Radiology & Oncology Pr. Thierry de Baere; Asst. Pr. Marcelo Guimaraes
    2:10 pm–2:50 pm Break and Exhibits
    2:50 pm–3:50 pm HCC - Evidence Based Debates   J.F. Geschwind, MD and Bien Soo Tan, MD
    2:50 pm–3:02 pm Chemoembolization is the Standard of Care and Should Remain as Such Michael C. Soulen, MD
    3:02 pm–3:14 pm Radioembolization is the Way to Go and Should Replace TACE as Standard of Care Riad Salem, MD
    3:14 pm–3:26 pm Small Particle Embo Is the Only Thing You Need Karen Brown, MD
    3:26 pm–3:38 pm Combination Therapies In HCC: Is It Needed? J.F. Geschwind, MD
    3:38 pm–3:50 pm How to Handle Advanced HCC and PV Thrombosis
    3:50 pm–4:00 pm Break and Exhibits
    4:00 pm–4:30 pm Renal Tumor Board   Moderators: Matthew Callstrom, MD and Jeremy Durack, MD
    Panelists: Fred Lee, MD; Debra Gervais, MD; David Breen, MD; Adam Feldman, MD; and Thomas Atwell, MD
    4:00 pm–5:20 pm Palliative Care  Hooman Yarmohammadi, MD and
    Alexis Kelekis, MD
    4:00 pm–4:15 pm Interventional Pain Management Alexis Kelekis, MD
    4:15 pm–4:30 pm Palliative Drainage Hooman Yarmohammadi, MD
    4:30 pm–4:45 pm Conservative Management of Chronic Pain Musa M. Aner, MD
    4:45pm–4:55 pm Venous Interventions in Cancer Patients Akhilesh Sista, MD
    4:55 pm–5:10 pm Enteric Drainage Ronald Arellano, MD
    5:10 pm–5:20 pm End of Life Care Mary Buss, MD
    4:45 pm–5:25 pm Post IO Imaging Advances Michael Brunner, MD and Philippe Pereira, MD
    4:45 pm–4:55 pm Post IO Imaging Advances Avinash Kambadakone, MD
    4:55 pm–5:05 pm How MRI Can Guide IO Treatments of Liver Tumors Jeff Weinreb, MD
    5:05 pm– 5:10 pm How MRI Can Improvee Outcomes of IO Therapies Philippe Pereira, MD
    5:15 pm–5:25 pm Alternatives to RECIST After IO Julius Chapiro, MD, PhD
    5:25 pm–5:35 pm Break and Exhibits
    5:30 pm–7:00 pm Abstract Presentations : HCC Treatments and Outcomes
    5:35 pm–7:05 pm Workshop: Musculoskeletal & Palliative Care Interventions  Moderator: Afshin Gangi, MD, PhD
    Speakers: Sean Tutton, MD; Dimitrios Filippiadis, MD; Kieran Murphy, MD; Frederic Deschamps, MD 
    7:00 pm–8:30 pm Corporate Advisory Council (invitation only)
    Sunday, 12 June
    Time General Session Speaker(s)
    8:00 am–9:30 am
    Workshop: Improving Outcomes with Intraprocedural Tumor Targeting and Monitoring Moderator: Suvranu Ganguli, MD
    Speakers: Paul Shyn, MD; Kelvin Hong, MD; Nadine Abi-Jaoudeh, MD 
    8:00 am–9:30 am Abstract Presentations: HCC, Imaging, and Monitoring
    9:30 am–9:45 am Break
    9:45 am–11:00am Metastatic Colorectal Tumor Board Moderators: Alban Denys, MD; Wiliam Rilling, MD; Daniel Brown, MD; Thomas Vogl, MD; and Constantinos Sofocleous, MD, PhD
    Panelists: Nancy Kemeny, MD;  Larry Blaszowsky, MD; and Theodore Hong, MD 
    11:00 am–11:15 am Break
    11:15 am–12:30 pm  My 5 Most Valuable Pearls  Dan Brown, MD and Thomas Helmberger, MD, PhD
    11:15 am–11:23 am Ablation HCC David Lu, MD
    11:23 am–11:31 am Ablation Liver Metastases Thomas Helmberger, MD
    11:31 am–11:39 am Ablation Lung Alice Gillams, MD
    11:39 am–11:47 am Ablation Bone Afshin Gangi, MD
    11:47 am–11:55 am Bland Embo/DEB-TACE Karen Brown, MD
    11:55 am–12:03 pm DEB-TACE William S. Rilling, MD
    12:03 pm–12:11 pm Oil TACE Yasuaki Arai, MD
    12:11 pm–12:19 pm Y90 Resin David C. Madoff, MD
    12:19 pm–12:27 pm Y90 Glass Microspheres Matthew Johnson, MD
    12:27 pm–12:35 pm Renal Ablation Raul Uppot, MD


    Workshop: Transcatheter Hepatic Oncologic Therapies